The American Heart Association and Laerdal Medical further commitment to provide equitable, increased access to high-quality ...
Epicor presented its Automotive Champion Awards for 2026 during the Epicor Insights for Automotive 2026 conference, Feb. 9-11, at the Tradewinds Resort, St. Pete Beach, FL. “Each award celebrates a ...
At WSJ Invest Live, Jon Gray shared optimism for the health of the private-credit market and discussed Blackstone’s investment strategy in AI infrastructure. Investors’ fears that new developments in ...
With software stocks badly trailing the rest of the tech sector of late, investors told CNBC that they're buying the dip and predicted a flurry of deals. Shares of Salesforce, ServiceNow and Adobe ...
Epicor, a global leader in industry-specific enterprise software, today announced key milestones in its product innovation strategy, including the schedule of final on-premises feature releases of ...
The autonomous vehicle industry is heating up thanks to advances in AI. But can those same innovations help startups like HyprLabs build safe tech? But using a small, agile, and cheap team to get from ...
Epicor Software was hit with a breach-of-contract lawsuit on Dec. 2 in New York Supreme Court for Albany County by business-services firm Vital Records Holdings (VRC). The suit, brought by Baker & ...
Epicor, a supplier of industry-specific enterprise software, has released Epicor Prism Business Communications, which it claims is “the industry’s first ERP (enterprise resource planning) AI agent ...
So, you’ve got a shiny new Garmin watch. Maybe it’s the sleek Vivoactive 6, the run-focused Forerunner 970, or (my favorite) the ultimate all-arounder Fēnix 8. You’re tracking your steps, sleep, ...
Cybersecurity-awareness training might not help employees avoid phishing attacks, a recent study suggests. The study involved nearly 20,000 employees at UC San Diego Health, a large California ...
Exploratory biomarker analysis of trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in HER2-low/ultralow, hormone receptor–positive (HR+) metastatic breast cancer (mBC) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results